Franklin Resources’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Franklin Resources’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-813,800	Closed	-$24.3M	–	1584
2017 Q1	$24.3M	Sell	813,800 -130,900	-14%	-$3.34M	0.01%	733
2016 Q4	$16.6M	Sell	944,700 -20,900	-2%	-$401K	0.01%	836
2016 Q3	$23M	Hold	965,600	–	–	0.01%	770
2016 Q2	$15.4M	Hold	965,600	–	–	0.01%	870
2016 Q1	$20.2M	Hold	965,600	–	–	0.01%	807
2015 Q4	$26.1M	Buy	965,600 +53,700	+6%	+$1.46M	0.01%	751
2015 Q3	$25.3M	Sell	911,900 -72,700	-7%	-$2.29M	0.01%	777
2015 Q2	$24.1M	Buy	984,600 +64,200	+7%	+$1.32M	0.01%	847
2015 Q1	$16.8M	Hold	920,400	–	–	0.01%	925
2014 Q4	$17M	Hold	920,400	–	–	0.01%	926
2014 Q3	$8.85M	Hold	920,400	–	–	﹤0.01%	1066
2014 Q2	$8.45M	Buy	+920,400	New	+$8.4M	﹤0.01%	1084

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources's LJPC Position: Q2 2017 in Review

Franklin Resources sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2017, closing a stake of 813,800 shares — an estimated $24.3M sold.

Franklin Resources first reported a position in LJPC in Q2 2014 and held it in 12 quarters. The position peaked at $26.1M in Q4 2015. 83 funds tracked by Wall St. Rank hold LJPC as of Q2 2017.

Franklin Resources reported no remaining La Jolla Pharmaceutical Company position as of Q2 2017 after selling out during the quarter.
Franklin Resources sold 813,800 La Jolla Pharmaceutical Company shares in Q2 2017, an estimated $24.3M.
Franklin Resources first reported a position in La Jolla Pharmaceutical Company in Q2 2014 and held it in 12 quarters.
Franklin Resources's La Jolla Pharmaceutical Company position peaked at $26.1M in Q4 2015.
83 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2017.

Based on Franklin Resources's 13F filing for Q2 2017, filed 10 Aug 2017.